← All organizations
Highest phase reached
Phase 2
First clinical trial
Apr 1, 2013Last known activity
Oct 6, 2025
Timeline
1990s
- Jun 1, 1998
Affibody— Founded
Drugs by trial phase (6 distinct, 9 trials)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (10)
- NCT07081555Lead sponsorPhase 1Oct 6, 2025
- NCT04706741Lead sponsorPhase 2Oct 31, 2021
- NCT04795141CollaboratorPhase 2Apr 26, 2021
- NCT04713072Overall official - principal investigatorPhase 2Aug 4, 2020
- NCT04713072Lead sponsorPhase 2Aug 4, 2020
- NCT03580278Lead sponsorPhase 1Jul 31, 2018
- NCT03591887Lead sponsorPhase 2Mar 7, 2018
- NCT03502954Lead sponsorPhase 1Feb 26, 2018
- NCT02690142Lead sponsorPhase 1Feb 1, 2016
- NCT01858116CollaboratorPhase 1/Phase 2Apr 1, 2013
Details
- Founded
- Stockholm, SE Jun 1, 1998
- Last known activity
- Oct 6, 2025